What's happening
This bill prohibits health insurers in New York from requiring prior authorization for anti-retroviral medications to treat or prevent HIV infection.
Why it matters
Streamlines access to lifesaving HIV treatments. By eliminating prior authorization, patients can obtain anti-retroviral medications more quickly, which is crucial for both treating those living with HIV and preventing new infections.
Reduces administrative burdens for healthcare providers. Doctors and clinics will spend less time on paperwork and insurance appeals, allowing them to focus more on patient care and improving overall efficiency in HIV prevention and treatment.
Addresses barriers to preventative care. Removing prior authorization requirements can help expand access to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), which are important tools in reducing HIV transmission, especially in communities at higher risk.
Maintains safeguards against inappropriate use. Insurers can still deny coverage if a medication is found not to be medically necessary, helping ensure responsible use of anti-retroviral drugs while prioritizing timely patient access.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
People living with HIV
The bill would bar covered health plans from requiring prior authorization for anti-retroviral medication used to treat HIV.
People using medication to prevent HIV
The bill would also prohibit prior authorization for anti-retroviral medication used to prevent HIV infection.
Health insurers and health care plans
Those providing prescription drug coverage would have to remove these prior authorization requirements but could still deny claims subsequently determined not medically necessary.
Clinicians prescribing HIV medication
The bill would eliminate the need to obtain prior authorization from covered plans for anti-retroviral medication used to treat or prevent HIV.
Headline styles
End HIV Med Prior Authorization
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Committed to rules
- Advanced to third reading
- 2nd report cal.
- 1st report cal.992
- Referred to health
- Referred to health
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
5374
2023-2024 Regular Sessions
IN SENATE
March 3, 2023
Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law and the insurance law, in relation to prohibiting health insurers from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 4406-c of the public health law is amended by adding a new subdivision 13 to read as follows:
13. A health care plan which provides prescription drug coverage shall not require a prior authorization determination for anti-retroviral medication used to treat and prevent HIV infection. Nothing in this subdivision shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.
§ 2. Section 3217-b of the insurance law is amended by adding a new subsection (p) to read as follows:
(p) An insurer which provides prescription drug coverage shall not require a prior authorization determination for anti-retroviral medication used to treat and prevent HIV infection. Nothing in this subsection shall prohibit an insurer from denying a claim for such services if the services are subsequently determined not medically necessary.
§ 3. Section 4325 of the insurance law is amended by adding a new subsection (p) to read as follows:
(p) A corporation organized under this article which provides prescription drug coverage shall not require a prior authorization determination for anti-retroviral medication used to treat and prevent HIV infection. Nothing in this subsection shall prohibit a corporation organized under this article from denying a claim for such services if the services are subsequently determined not medically necessary.
§ 4. This act shall take effect on the one hundred eightieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09965-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law and the insurance law, in relation to prohibiting health insurers from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection
Purpose
Prohibits health insurers from requiring prior authorization for antire- troviral medication used to treat and prevent HIV infection
Summary of provisions
Section 1 amends section 4406-c of the public health law by requiring health care plans which provide prescription drug coverage shall not require a prior authorization determination for antiretroviral medica- tion used to treat and prevent HIV infection. Nothing in this subdivi- sion shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.
Section 2 amends section 3217-b of the insurance law which provides that an insurer that provides prescription drug coverage shall not require a prior authorization determination for antiretroviral medication used to treat and prevent HIV infection. Nothing in this subdivision shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.
Section 3 amends section 4325 of the insurance law by providing that a corporation organized under this article that provides prescription drug coverage shall not require a prior authorization determination for antiretroviral medication used to treat and prevent HIV infection. Noth- ing in this subdivision shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.
Section 4 states the effective date
Justification
According to the New York State Department of Health (DOH), there are 103,900 New Yorkers living with human immunodeficiency virus (HIV), many of whom rely on antiretroviral medications to manage their symptoms. Countless individuals regularly rely on antiretroviral medications to prevent becoming infected with HIV.
Time is a crucial factor in the efficacy of these medications. Persons diagnosed with HIV are advised to start antiretroviral therapy as soon as possible to minimize damage to their immune systems and their risk of developing AIDS. After being exposed to HIV, an individual must receive antiretroviral medication within seventy-two hours to prevent infection. Preauthorization can take days, putting the health of those infected with and those exposed to HIV at risk.
Administrative costs of the preauthorization process can be high, which can place a financial burden on healthcare providers. This legislation will ensure New Yorkers living with HIV are able to receive their medi- cation in a timely manner, and that healthcare providers are able to give their HIV-positive patients the best care they possibly can.
Legislative history
2021-2022: S8981 - Died in Health
Fiscal implications
None to the State.
Effective date
This act shall take effect on the one hundred eightieth day after it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.